Ruben Marques Selected Research

Therapeutics

1/2021

Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruben Marques Research Topics

Disease

15	Tuberous Sclerosis (Bourneville's Disease) 12/2021 - 01/2017
4	Angiomyolipoma 01/2020 - 01/2017
4	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2017
3	Epilepsy (Aura) 01/2021 - 01/2019
2	Infantile Spasms (West Syndrome) 01/2021 - 03/2019
2	Seizures (Absence Seizure) 01/2021 - 03/2019
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019 - 01/2017
1	Hamartoma 12/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Angiofibroma 01/2017
1	Rhabdomyoma 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017

Drug/Important Bio-Agent (IBA)

16	trans-sodium crocetinate (crocetin)IBA 12/2021 - 01/2017
1	Everolimus FDA Link 01/2021
1	SteroidsIBA 01/2021
1	Vigabatrin FDA Link 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 03/2019
1	gamma-Aminobutyric Acid (GABA)IBA 03/2019
1	MTOR InhibitorsIBA 01/2019
1	lipoarabinomannan (LAM)IBA 01/2019

Therapy/Procedure

1	Therapeutics 01/2021